July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Persistent leaking in long term follow-up in the primate model of DL-2-aminoadipic acid-induced retinal neovascularization and vascular leakage
Author Affiliations & Notes
  • Wenzheng Hu
    RxGen Inc, New Haven, Connecticut, United States
  • Donnicia James
    RxGen Inc, New Haven, Connecticut, United States
  • Vernard Woodley
    RxGen Inc, New Haven, Connecticut, United States
  • Chintan Patel
    RxGen Inc, New Haven, Connecticut, United States
  • Anish Kurian
    RxGen Inc, New Haven, Connecticut, United States
  • Matthew S Lawrence
    RxGen Inc, New Haven, Connecticut, United States
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 5483. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Wenzheng Hu, Donnicia James, Vernard Woodley, Chintan Patel, Anish Kurian, Matthew S Lawrence; Persistent leaking in long term follow-up in the primate model of DL-2-aminoadipic acid-induced retinal neovascularization and vascular leakage. Invest. Ophthalmol. Vis. Sci. 2018;59(9):5483.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To characterize the long term retinal vascular changes resulting from intravitreal (IVT) injection of DL-2-aminoadipic acid (DLAAA) in the green monkey. The effect of anti-vascular endothelial growth factor (anti-VEGF) treatment on the induced retinal vascular leakage was also evaluated to validate the model for repeated dosing and screening of candidate compounds.

Methods : Adult St. Kitts green monkeys (Chlorocebus sabaeus) that had previously received an IVT injection of 5 mg DLAAA and developed various degree of retinal vascular leakage were included in the study. Ophthalmic examinations including slit lamp biomicroscopy, color fundus photography (CFP), fluorescein angiography (FA) and optical coherence tomography (OCT) were conducted up to 18 months. The area and fluorescence intensity of retinal vascular leakage were quantified from the 1 and 3 minute angiograms by Amira software. The retinal histopathologic change following long term leakage and the effect of IVT aflibercept were evaluated in representative eyes with various degree of retinal pathology.

Results : The area and fluorescence intensity of retinal vascular leakage was remained between Month 4 and Month 8 fluorescein angiograms. By Month 18 the leakage persisted in all eyes, however, a reduced lesion area size and fluorescence intensity was observed. CFP and OCT demonstrated a similar retinal phenotype and morphological pattern between Month 8 and Month 18. The results of ongoing anti-VEGF efficacy and histopathology evaluations will provide additional insight into the persisting nature of the DLAAA model.

Conclusions : DLAAA-induced retinal neovascularization and leakage persists through 18 months in the green monkey. The retinal phenotype is stable in the observation period up to 18 months, supporting the application of DLAAA-induced retinal vascular leakage as a primate model for efficacy evaluations of candidate therapeutics targeting retinal vascular leakage, including those with long duration of effect.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×